drugtargetreview.com Report : Visit Site

Technical data of the drugtargetreview.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host drugtargetreview.com. Currently, hosted in United States and its service provider is CloudFlare Inc. .

the related websites

terrapinn.com abc.org.uk link.springer.com russellpublishing.com drugdiscoverytoday.com instem.com journals.elsevier.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

about us | advertise with us | contact us follow: menu home news articles publications webinars products whitepapers / app notes content hubs events targets screening stem cells hit-to-lead omics imaging informatics regs & legs a universal flu vaccine may be in sight researchers from oxford have identified the initial steps on the path towards creating a universal influenza vaccine that could last for life... nlrp12 protein promotes healthy gut bacteria to curb obesity scientists have discovered that the anti-inflammatory protein nlrp12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet... scientists develop means to manipulate nuclear pore numbers researchers in california have developed a method to facilitate control of nuclear pore numbers in cells. the capability is expected to glean valuable information to aid cancer treatment. a wearable device for hair regrowth researchers have developed a method of using vertical micro-light-emitting diodes in a small stamp-sized patch to enable hair regrowth... latest news mitochondrial diseases could be treated with gene therapy latest news protein ‘trafficker’ provides insight into autism latest news nanotherapy offers hope in treating drug-resistant renal cell carcinoma latest news cancer cells hide to evade immunotherapy latest news a universal flu vaccine may be in sight whitepaper tech note: detection of immune checkpoint markers in peripheral blood mononuclear cell lysates with alphalisa upstream bioprocessing in-depth focus 2018 event discovery on target from our latest issue... pharmacological targeting of mitochondrial dysfunction in parkinson’s disease: approaches and perspectives synthetic biology in drug discovery improved screening of therapeutic candidates using integrated fragment-based approaches expert view: the development of single‑cell genomics with smart‑seq cell-based and biochemical high-throughput screening in 1536 well plates webinar integrated fragment-based approach reveals enzymatic inhibitors with potential therapeutic application content hub idea bio-medical ltd. most popular... pharmacological targeting of mitochondrial dysfunction in parkinson’s disease: approaches and perspectives nlrp12 protein promotes healthy gut bacteria to curb obesity scientists develop means to manipulate nuclear pore numbers new understanding of t-cell receptor behaviour presents challenge for immunotherapies class of neurological disorders share 3d genome folding pattern read the latest issue all subscriptions include online membership, giving you access to the journal and exclusive content. subscribe today content articles news whitepapers & app notes corporate content webinars blogs events products issue archive topics targets screening stem cells hit-to-lead omics imaging informatics regs & legs advertising & editorial media planner publishing schedule advertising opportunities advertising tech specs author information advisory board write for us | advertise with us contact register t: +44 (0)1959 563311 f: +44 (0)1959 563123 company information drug target review is published by: russell publishing ltd. court lodge hogtrough hill brasted, kent, tn16 1nu united kingdom about terms & conditions privacy policy © russell publishing limited , 2010-2018. all rights reserved. website development by e-motive media limited . we use cookies to improve your experience on our site and to show you relevant advertising. accept reject read more \r\n ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"plain","tracking_enabled":true}}},"30028_3":{"elementid":["drugt-43ab8dd42063ad7bfa632fb61a0ae93f"],"ads":{"30028":{"id":30028,"title":"[ad butler] leaderboard - fallback #1","expiry_date":1538348340,"visitors":[{"type":"device_width","operator":"is_higher","value":"781"},{"type":"device_width","operator":"is_lower","value":"1080"}],"content":" \r\n \r\n ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"plain","tracking_enabled":true}}},"30029_5":{"elementid":["drugt-04f46edc7fde3c46a20d0f6584b37ad3"],"ads":{"30029":{"id":30029,"title":"[ad butler] leaderboard - fallback #2","expiry_date":1538348340,"visitors":[{"type":"device_width","operator":"is_lower","value":"780"}],"content":" \r\n \r\n ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"plain","tracking_enabled":true}}},"30042_7":{"elementid":["drugt-ab7f0a087e63886f99b82373523e91da"],"ads":{"30042":{"id":30042,"title":"[ad butler] sidebar 300x100","expiry_date":0,"visitors":[{"type":"device_width","operator":"is_higher","value":"781"}],"content":" \r\n \r\n ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"plain","tracking_enabled":true}}},"30042_9":{"elementid":["drugt-2fe48b13cab2b9320413a6aa38eef0a5"],"ads":{"30042":{"id":30042,"title":"[ad butler] sidebar 300x100","expiry_date":0,"visitors":[{"type":"device_width","operator":"is_higher","value":"781"}],"content":" \r\n \r\n ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"plain","tracking_enabled":true}}}}; var advads_passive_groups = {}; var advads_passive_placements = {"before-you-go_11":{"elementid":["drugt-a55522d3d283164f5a668267366225bd"],"ads":{"31675":{"id":31675,"title":"[pop-up] membership - before you go","expiry_date":0,"visitors":[{"type":"cookie","operator":"hide","cookie":"zmember_logged","value":""},{"type":"device_width","operator":"is_higher","value":"781"}],"content":" \u00d7 ","once_per_page":0,"debugmode":false,"blog_id":1,"type":"image","tracking_enabled":true}},"type":"ad","id":31675,"placement_info":{"type":"layer","name":"before you go","item":"ad_31675","options":{"cache-busting":"auto","ad_label":"default","layer_placement":{"offset":"0","trigger":"exit","delay_sec":"0","effect":"slide","duration":"50","background":"1","background_click_close":"1","auto_close":{"trigger":"timeout","delay":"30"},"close":{"enabled":"1","where":"inside","side":"right","timeout_enabled":"true","timeout":"1"},"sticky":{"assistant":"center","position":{"width":"0","height":"0"}}},"placement_width":"500","placement_height":"357"},"id":"before-you-go"},"test_id":null}}; var advads_ajax_queries = []; var advads_has_ads = [["30030","ad",null],["32477","ad",null]]; ( window.advanced_ads_ready || jquery( document ).ready ).call( null, function() {if ( window.advanced_ads_pro ) {advanced_ads_pro.process_passive_cb();} else if ( window.console && window.console.log ) {console.log('advanced ads pro: cache-busting can not be initialized');}});

URL analysis for drugtargetreview.com

https://www.drugtargetreview.com/core_topic/stem-cells
https://www.drugtargetreview.com/news_type/blog
https://www.drugtargetreview.com/publications/
https://www.drugtargetreview.com/article/35250/upstream-bioprocessing-in-depth-focus-2018/
https://www.drugtargetreview.com/news/35676/universal-influenza-vaccine/
https://www.drugtargetreview.com/events/33035/discovery-on-target/
https://www.drugtargetreview.com/core_topic/imaging
https://www.drugtargetreview.com/core_topic/targets/
https://www.drugtargetreview.com/events
https://www.drugtargetreview.com/core_topic/regs-legs
https://www.drugtargetreview.com/news/35594/manipulate-nuclear-pore-numbers/
https://www.drugtargetreview.com/whitepaper/
https://www.drugtargetreview.com/product
https://www.drugtargetreview.com/core_topic/omics
https://www.drugtargetreview.com/terms-conditions

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: DRUGTARGETREVIEW.COM
Registry Domain ID: 1824154786_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enom.com
Updated Date: 2019-08-04T14:00:30Z
Creation Date: 2013-08-29T10:29:35Z
Registry Expiry Date: 2020-08-29T10:29:35Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: ERIN.NS.CLOUDFLARE.COM
Name Server: RAM.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2019-08-11T17:57:01Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR eNom, LLC

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =drugtargetreview.com

  PORT 43

  TYPE domain

DOMAIN

  NAME drugtargetreview.com

  CHANGED 2019-08-04

  CREATED 2013-08-29

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  ERIN.NS.CLOUDFLARE.COM 173.245.58.113

  RAM.NS.CLOUDFLARE.COM 173.245.59.225

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .